Τόμος 14 (2000) – Τεύχος 1 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 14 (2000) – Issue 1 – Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Author

Laboratory of inorganic and Pharmaceutical Analytical Chemistry, Department of Chemistry, University of Ioannina, GR-451 10 Ioannina, Hellas (Greece)

Accepted for publication: 10 November 1999

pharmakonpress[at]pharmakonpress[.]gr

2.    Brockmann H., Lindemann E., Ritter K-H., Depke F.: Uber Oxy-Deriyate des Helianthrens und meso-Naphthodianthrens; zur Konstitution des Hypericins. ΙΙΙ. Mitteilung: Chem. Ber. 61: 583-593 (1950)

3.    Brockmann H., Falkenhausen E.H.F., Dorlars A.: Die Konstitution des Hypericins. Naturwiss 37: 540 (1950)

4.    Brockmann H., Kluge F.: Zur Synthese des Hypericins. Naturwiss. 38: 141 (1951)

5.    Brockmann H., Falkenhausen E.H.F., Neeff R., Dorlars A., Budde G.: Die Konstitution des Hypericins. Chem. Ber. 64: 865-889 (1951)

6.    Brockmann H., Muxfeldt H.: Die Synthese des Hypericins. Naturwiss. 40: 411 (1953)

7.    Brockmann H., Kluge F., Muxfeldt H.: Totalsynthese des Hypericins. Chem. Ber. 90: 2302-2318(1957)

8.    Bianchιni F., Fantano A.C.: In: Guide to Plants and Flowers (Simon & Schuster, eds), p. 361, New York, 1974

9.    Liebes L., Mazur Y., Freeman D., Lavie D., Lavie G., Kudler N., Mentoza S., Levin B., Höchster H., Meruelo D.: A method for the quantitation of Hypericin, an antiviral agent, in biological fluids by HPLC. Anal. Biochem. 195: 77-85 (1991)

10.  Nafis M., Jardon P.: Propriétés spectroscopiques et photophysiques de complexes métalliques de l’hypericine en relation avec leur activité photodynamique. J. Chim. Phys. 91: 99-112 (1994)

11.  Micali G., Lanuzza F., Curro P.: HPLC-determination of the biologically active principle hypericin in phytotherapeutic vegetable extracts and alcoholic beverages. J. Chromatogr. 731: 336-339 (1996)

12.  Kartnig Th., Göbel L: Determination of Hypericin and Pseudohypericin by thin-layer chromatography-densitometry. J. Chromatogr. 609: 423-426 (1992)

13.  Φωκάς Γ.: Ειδική Φαρμακογνωσία. Σελ. 281,283, 284, Θεσσαλονίκη, 1975

14.  Λίντσκι Μ.Ι.: Φαρμακοθεραπεία των Εσωτερικών Παθήσεων. Εκδ. Γρ,Κ, Παρισιάνος, σελ. 324, 474, 483, Αθήνα, 1959

15.  Hoffmann D.: Η Νέα Ολιστική Βοτανοθεραπεία. Εκδ. Διόπτρα, σελ. 417, Αθήνα, 1997

16.  Launert E.: In: The Hamlyn Guide to Edible & Medicinal Plants of Britain and Northern Europe. The Hamlyn Publishing Group Ltd., pp. 40-41, London, 1989

17.  Tonero A.: Therapeutic product for the treatment of several diseases, such as rheumatism. Belg. Patent 654,916, 16.02.1965, Chem. Abstr. 92, 759-761, 1966)

18.  Hadjur C., Richard M.J., Parat M.O., Jardon P., Favier A.: Photodynamic effects of Hypericin on lipid peroxidation and antioxidant status in melanoma cells. Photochem. Photobio. 64: 375-381 (1996)

19.  Couldwell W.T..: Hypericin: a potential antiglioma therapy. Neurosurgery 35: 705-710 (1994)

20.  Moraleda G., Wu T.T., Jilbert A.R. et al.: Inhibition of duck Hepatitis В virus replication by Hypericin. Antiviral. Res. 20: 235-247 (1993)

21.  Degar S., Lavie G., Meruelo D.: Photodynamic inactivation of radiation Leucemia virus produced from Hypericin-treated cells. Virology 197: 796-800 (1993)

22.  Cohen P.A., Hudson J.B., Towers G.H.: Antiviral activities of Anthraquinones, Bianthrones and Hypericin derivatives from Lichens. Experientia 52: 180-183 (1996)

23.  Kraus G.A., Pratt D., Tossberg J., Carpenter S.: Antiretroviral activity of synthetic Hypericin and related analogs. Biochem. Biophys. Res. Commun. 172: 149-153 (1990)

24.  Takahashi O., Nakanishi S., Kobayashi E., Nakano H., Suzuki K., Tamaoki T.: Hypericin and Pseudohypericin specifically inhibit Protein kinase C possible relation to their antiretroviral activity. Biochem, Biophys. Res. Commun. 65: 1207-1212(1989)

25.  Lavie G., Valentine F., Levin B., et al.: Studies of the mechanisms of action of the antiretroviral agents Hypericin and Pseudohypericin. Proc. Natl. Acad. Sci. USA 86: 5963- 5967 (1989)

26.  Meruelo D., Lavie G., Lavie D.: Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones Hypericin and Pseudohypericin. Proc. Natl. Acad. Sci. USA 85: 5230-5234 (1988)

27.  Nishiuchi T., Utsumi T., Kanno T., et al.: Inhibition of neutrophil superoxide generation by Hypericin, an antiretroviral agent. Arch .Biochem. Biophys. 323: 335-342 (1995)

28.  Utsumi T., Okuma M., Kanno T., et al.: Light-dependent inhibition of Protein kinase C and superoxide generation of neutrophils by Hypericin, an antiretroviral agent. Arch. Biochem. Biophys. 316: 493-497 (1995)

29.  Okpanyi S.N., Lidzba H., Scholl B.C., Miltenburger H.G.: Genotoxicity of a standardized Hypericum extract. Arzneimitteiforchung 40: 851-855 (1990)

30.  Neuman,H.: Skin food with new active substances. Selfen-Ole-Fette-Wachae 92: 759-761 (1966)

31.  Sharikova K.K., Garagulya A.D., Khazanovich R.L.: Antimicrobial properties of some species of St.John’s wort cultivated in Uzbekistan. Mikrobiol. Zh. 32: 494-497 (1970)

32.  Omel’chuk-Myakushko T.Ya., Fastovskaya A.Ya.: Dynamics of the accumulation of antimicrobic substances in Hypericum perforatum. Rast. Resur.: 346-349 (1968)

33.  Lui H., Anderson R.R.: Photodynamic therapy in Dermatology: recent developments. Dermatol. Clin. 11: 1- 13(1993)

34.  Agostinis P., Vandenbogaerde A., Donella-Deana A., et al.: Photosensitized inhibition of growth factor-regulated Protein kinases by Hypericin. Biochem. Pharmacol. 49: 1615-1622 (1995)

35.  Agostinis P., Donella-Deana A., Cuveele J., et al.: A comparative analysts of the photosensitized inhibition of growth-factor regulated Protein kinases by Hypericin-derivatives. Biochem. Biophys, Res. Commun. 220: 613- 617 (1996)

36.  Evstifeeva T.A., Sibîriak S.V.: The immunotropic properties of biologically active products obtained from Klamath weed (Hypericum perforatum L). Eksp. Klin. Farmakol. 59: 51-54(1996)

37.  Harris M.S., Sakamoto T., Kimura K, et al.: Hypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of Protein kinase C. Curr, Eye Res 15: 255-262 (1996)

38.  Miskovsky P., Sureau F., Chinsky L, Turpin P.Y.: Subcellular distribution of Hypericin in human cancer cells. Photochem. Photobiol. 62: 546-540(1995)

39.  Zhang W., Lawa R.E., Hintona D.R., Su Y., Couldweell W.T.: Growth inhibition and apoptosis in human neuroblastoma SK-N-SH-cells, induced by Hypericin, a potent inhibitor of Protein kinase C. Cancer Lett. 96: 31-35 (1995)

40.  Jarvis W.D., Turner A.J., Povirk L.F., Traylor R.S., Grant S.: induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leucemia cells by pharmacological inhibitors of Protein kinase C. Cancer Res. 54: 1707-1714(1994)

41.  Gopalakrishna R., Chen Z.H., Gundimeda U.: Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of Protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc. Natl. Acad. Sci. USA 91: 12233-12237 (1994)

42.  VanderWerf Q.M., Saxton R.E., Chang A., et al.: Hypericin: a new laser phototargeting agent for human cancer cells. Laryngoscope 106: 479-483 (1996)

43.  Vandenbogaerde A.L., Geboes K.R., Cuveele J.R, Agostinis P.M., Merievede W.J., de Witte P.A.: Antitumor activity of photosensitized Hypericin on A431 cell xenografts. Anticancer Res. 16: 1619-1625(1996)

43a. Vandenbogaerde A.L, Cuveele J.F., Proot P., Him- pens B.E., Merievede W.J., de Witte, P.A. J. Photochem. Photobiol. B. 38: 136-142 (1997)

43b. Vandenbogaerde A.L., Delaey E.M., Vantieghem A.M., Himpens B.E., Merievede W J., de Witte P.A.: Photochem. Photobiol. 67: 119-125 (1998)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr